CVE-2022-48221
What it is
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).
At a glance
- Exploitability
- Can be exploited over the network with a low-privilege account. High risk of data exposure, data tampering, service disruption.
- Exploit odds
- 0.5% chance of exploitation in the next 30 days (EPSS).
- Fix
- No patch or advisory is linked yet. Look at mitigations or restrict exposure.
Timeline
- PublishedDisclosed publicly on CVE.org and NVD
- Last updatedMost recent change to the record
Why it ranks here
- Exploited in the wild: no, CISA does not list it.
- Exploit odds: 0.5% in the next 30 days (EPSS).
- Severity: 7.5 HIGH (CVSS).
- Fix: none linked yet, which raises it.
Details
- Published
- Last modified
- Exploit probability
- 0.5% · EPSS, next 30 days
- Weakness
- CWE-362 · Race condition
- Record status
- Modified
Affected
- Gbgplc Acuant Acufill Sdk < 10.22.02.03
Attack profile CVSS 3.1 · 7.5
- Attack vector
- Network
- Complexity
- High
- Privileges needed
- Low
- User interaction
- None
- Scope
- Unchanged
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Raw vector
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
Is it in your code?
Hand this to your coding agent. It searches your project for the affected products and checks versions. Nothing leaves your machine.
Read https://cve-list.com/agent/cve/CVE-2022-48221.md and follow it. Check whether this project is affected by CVE-2022-48221. Read only. Don't change anything and don't upload my code. Tell me yes, no or not sure, with the file as proof.
